[1] CULBERTSON E M, BRUNO V M, CORMACK B P, et al. Expanded role of the Cu-sensing transcription factor Mac1p in Candida albicans[J]. Molecular Microbiology, 2020, 114(6): 1006-1018. [2] 吴茂江,涂长信.铜与人体健康[J].微量元素与健康研究,2005,22(5):64-65. WU M J, TU C X. Copper and human health[J]. Studies of Trace Elements and Health, 2005, 22(5): 64-65(in Chinese). [3] 彭 源,卢毅飞,邓 君,等.氧化铜纳米酶对糖尿病小鼠全层皮肤缺损创面修复的作用及其机制[J].中华烧伤杂志,2020,36(12):1139-1148. PENG Y, LU Y F, DENG J, et al.Effects and mechanism of copper oxide nanozymes on wound healing of full-thickness skin defects in diabetic mice[J]. Chinese Journal of Burns,2020, 36(12): 1139-1148(in Chinese). [4] 岳爱琴,张宇婷,张鹏骞,等.两个dpa类配体的铜(Ⅱ)配合物的合成、结构、核酸酶活性及细胞毒性(英文)[J].无机化学学报,2017,33(12):2287-2295. YUE A Q, ZHANG Y T, ZHANG P Q, et al. Two copper(Ⅱ) complexes with dpa-based ligand: syntheses, structures, nuclease activity and cytotoxicity[J]. Chinese Journal of Inorganic Chemistry, 2017, 33(12): 2287-2295. [5] 王大伟,周林宗,杨思林,等.2-羟基萘-1-甲醛Cu(Ⅱ)配合物的合成、晶体结构和抗菌活性[J].化学试剂,2017,39(12):1259-1262+1310. WANG D W, ZHOU L Z, YANG S L, et al. Synthesis, crystal structure and antifungal activities of Cu(Ⅱ) complex based on 2-hydroxynaphthalene-1-carbaldehyde[J]. Chemical Reagents, 2017, 39(12): 1259-1262+1310(in Chinese). [6] 邓 燕,刘 慧,张飞旭,等.槲皮苷铜配合物作为P-糖蛋白抑制剂的研究[J].华东理工大学学报(自然科学版),2020,46(5):680-687. DENG Y, LIU H, ZHANG F X, et al. Study on Cu-quercitrin as a novel P-gp inhibitor[J]. Journal of East China University of Science and Technology, 2020, 46(5): 680-687(in Chinese). [7] CUI Y H. Binding of levobupivacaine-loaded gold nanoparticles to human serum albumin: a simulated physiological study[J]. Luminescence, 2020, 35(8): 1269-1276. [8] 饶希午,沈卫星,谭佳妮,等.消癌解毒方对肝癌模型大鼠血清蛋白差异表达的蛋白质组学研究[J].中医杂志,2018,59(22):1953-1958. RAO X W, SHEN W X, TAN J N, et al.Proteomic analysis study on effects of xiaoai jiedu decoction on expressions of serum differential proteins in liver cancer model rats[J]. Journal of Traditional Chinese Medicine, 2018, 59(22): 1953-1958(in Chinese). [9] 熊时鹏.抗肿瘤药物与HSA的相互作用及分子模拟[D].上海:上海师范大学,2018. XIONG S P. Interaction between antitumor drugs and HSA and molecular simulation[D]. Shanghai: Shanghai Normal University, 2018(in Chinese). [10] ZENG Z F, HUANG Q P, CAI J H, et al. Synthesis, characterization, DNA/HSA interactions, and anticancer activity of two novel copper(Ⅱ) complexes with 4-chloro-3-nitrobenzoic acid ligand[J]. Molecules, 2021, 26(13): 4028. [11] 李可欣,罗幸玲,张凌燕,等.纳米二氧化硅暴露对金属硫蛋白和人血清白蛋白二级结构的影响[J].中国药理学与毒理学杂志,2021,35(2):116-122. LI K X, LUO X L, ZHANG L Y, et al. Effect of silica nanoparticle exposure on secondary structure of metallothionein and human serum albumin[J]. Chinese Journal of Pharmacology and Toxicology, 2021, 35(2): 116-122(in Chinese). [12] 宋玉民,张 琼,李清萍,等.抗凝血药物华法灵钠与人血清白蛋白的相互作用研究[J].西北师范大学学报(自然科学版),2011,47(1):48-52+58. SONG Y M, ZHANG Q, LI Q P, et al. Studies on interaction between the anticoagulants warfarin and human serum albumin[J]. Journal of Northwest Normal University (Natural Science), 2011, 47(1): 48-52+58(in Chinese). [13] 杨曼曼,席小莉,柴晓波,等.核酸与抗癌药物的作用和广义荧光猝灭方程[J].分子科学学报,2014,30(6):448-454. YANG M M, XI X L, CHAI X B, et al. Interactions of nucleic acid with anticancer drugs and generalized fluorescence quenching equation[J]. Journal of Molecular Science, 2014, 30(6): 448-454(in Chinese). [14] CHAVES O A, MENEZES L B, IGLESIAS B A. Multiple spectroscopic and theoretical investigation of meso-tetra-(4-pyridyl)porphyrin-ruthenium(Ⅱ) complexes in HSA-binding studies. Effect of Zn(Ⅱ) in protein binding[J]. Journal of Molecular Liquids, 2019, 294: 111581. [15] ABYAR F, TABRIZI L. Experimental and theoretical investigations of novel oxidovanadium(Ⅳ) juglone complex: DNA/HSA interaction and cytotoxic activity[J]. Journal of Biomolecular Structure and Dynamics, 2020, 38(2): 474-487. [16] DA SILVA M M, DE CAMARGO M S, CORREA R S, et al. Non-mutagenic Ru(Ⅱ) complexes: cytotoxicity, topoisomerase IB inhibition, DNA and HSA binding[J]. Dalton Transactions, 2019, 48(39): 14885-14897. |